Acceleron signs pulmonary research and discovery deal with Fulcrum Therapeutics

This article was originally published here

As part of the collaboration and licence agreement, the companies will work together to detect small molecules designed to modulate specific pathways linked with a targeted indication within

The post Acceleron signs pulmonary research and discovery deal with Fulcrum Therapeutics appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply